The Portfolio of R&D Projects

Lyonbiopôle’s R&D focuses on:

- diagnostics

- vaccines and new therapies against infectious diseases

1) Multi-partner projects with public and private funding:

• Projects selected and funded by the Enterprise Competitiveness Fund (FCE)
• Projects selected and funded by the European Commission
• Projects selected and funded by the French National Research Agency (ANR)
  16 accredited projects were selected by the ANR in 2005 and 2006.
  
  

Summary - Key figures on the projects in 2005 and 2006

• The Enterprise Competitiveness Fund (FCE):
  6 projects        €61.2 million in spending         €16.6 million in funding granted
• The National Research Agency (ANR):
  14 projects      €20 million in spending           €8 million in funding granted
• European Commission:
  2 projects         €5.4 million in spending          €3.4 million in funding notified
• In all:
  22 projects     €86.6 million in spending     €28 million in public funding granted

2) Collaborative projects with Research Networks

Lyonbiopôle works with various research networks:

The "Innovations in Infectiology" RTRA

Lyonbiopôle is a founding member of the "Innovations in Infectiology" Advanced Research Topic Network (RTRA) selected by the French State. 

For more information: - PDF 12Ko 

- CLARA (The Lyon Auvergne Rhône-Alpes Cancer Cluster)

A product of the French National Cancer Plan and National Cancer Institute, the cluster makes a vital contribution to the national policy for the fight against cancer…

For more information: PDF 12Ko

www.canceropole-lara.com

- Research clusters in Rhône-Alpes

In 2005, the Rhône-Alpes Region initiated the creation of research clusters…

For more information: PDF 17 Ko
http://www.universite-lyon.fr/21989005/0/fiche  

- The ADNA program funded by the French Industrial Innovation Agency (AII)

Le The Advances in Diagnostics for New Therapies (ADNA) program, coordinated by Mérieux Alliance…

For more information: PDF 12 Ko

- The NanoBio Innovation Cluster

NanoBio is an innovation and biotech cluster for the biology and healthcare fields, uniting Grenoble-area teams…

For more information: PDF 12 Ko
http://www.nano2life.org/

- The VirGil European Excellence Network

Virgil is composed of 55 institutes based in 12 European countries and 7 pharmaceutical or biotech firms. It receives funding from the European Union and is actively supported by the Rhône-Alpes Region.

The Virgil network, a partner of Lyonbiopôle, is coordinated in Lyon.

- The Center for Integrated Structural Biology (CISB)

The Center for Integrated Structural Biology (CISB) is a European center of excellence in integrated structural biology…

For more information: PDF 12 Ko

3) Advantages obtained by Lyonbiopôle for project funding

Lyonbiopôle offers its members support and project setup services and handles coordination of public funding providers.

The cluster has obtained the following:

• Co-funding of projects by all local authorities alongside the French State

• A pluriannual program for funding of R&D projects by local authorities

• Coverage of 45% of the expenses incurred by each SMB for their R&D projects funded by the Enterprise Competitiveness Fund (FCE)

• The majority of funding for Laboratories and SMBs (partners or subcontractors)

• A strong position with the European Commission prior to the startup of the 7th Framework Program on Research and Development (FP7)